Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.

@article{Simpson2014FertilityST,
  title={Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.},
  author={Andrea N Simpson and Tomer Feigenberg and Blaise Alexander Clarke and Lilian T. Gien and Nadia D Ismiil and St{\'e}phane Laframboise and Christine Massey and Sarah E. Ferguson},
  journal={Gynecologic oncology},
  year={2014},
  volume={133 2},
  pages={229-33}
}
OBJECTIVE Oral progestin is an alternative to hysterectomy for women with complex atypical hyperplasia (CAH) or grade one endometrial cancer (G1EC) who wish fertility preservation. We evaluated treatment efficacy and fertility outcomes in this population. METHODS Women <45 y treated with oral progestin for CAH or G1EC were identified from two cancer centers. Data were obtained from medical records and telephone questionnaires. Time until complete response (CR), and from CR until recurrence… CONTINUE READING
15 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…